1887

Abstract

The SAM-P1 strain of senescence-accelerated model mice shows an impaired T helper type 1 (Th1) immune response upon infection with influenza virus, which results in high susceptibility to the virus. Treatment of spleen cells from SAM-P1 mice with an immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif (CpG ODN) increased the ratio of the titre of IFN- to that of IL-4. Administration of CpG ODN to SAM-P1 mice generated satisfactory virus-specific cytotoxic T-lymphocyte responses and natural killer cell activation and the virus-specific immunoglobulin (Ig) isotype switched from IgG1 to IgG2a. Virus growth in the lungs of CpG ODN-treated SAM-P1 mice was cleared quickly and mice survived the lethal influenza virus infection. It could be inferred that a possible mechanism of CpG ODN for normalization of senescence-associated dysregulation of the Th1/Th2 balance involves the upregulated expression of CD154 and CD40 molecules on immune-competent cells. These results suggest that CpG ODN could contribute to the development of a protective strategy against infectious diseases, especially among immunocompromised elderly persons, by stimulating Th1 immune responses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19029-0
2003-06-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/6/vir841623.html?itemId=/content/journal/jgv/10.1099/vir.0.19029-0&mimeType=html&fmt=ahah

References

  1. Bender, B. S., Johnson, M. P. & Small, P. A. ( 1991; ). Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology 72, 514–519.
    [Google Scholar]
  2. Brazolot Millan, C. L., Weeratna, R., Krieg, A. M., Siegrist, C. A. & Davis, H. L. ( 1998; ). CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A 95, 15553–15558.[CrossRef]
    [Google Scholar]
  3. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. & Alber, G. ( 1996; ). Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184, 747–752.[CrossRef]
    [Google Scholar]
  4. Cho, H. J., Takabayashi, K., Cheng, P. M., Nguyen, M. D., Corr, M., Tuck, S. & Raz, E. ( 2000; ). Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol 18, 509–514.[CrossRef]
    [Google Scholar]
  5. Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann, P. V. & Harding, C. V. ( 1997; ). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186, 1623–1631.[CrossRef]
    [Google Scholar]
  6. Davis, H. L. ( 2000; ). Use of CpG DNA for enhancing specific immune responses. Curr Top Microbiol Immunol 247, 171–183.
    [Google Scholar]
  7. Decker, T. & Lohmann-Matthes, M. L. ( 1988; ). A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115, 61–69.[CrossRef]
    [Google Scholar]
  8. Dong, L., Mori, I., Hossain, Md. J. & Kimura, Y. ( 2000; ). The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis 182, 391–396.[CrossRef]
    [Google Scholar]
  9. Gardner, E. M. & Murasko, D. M. ( 2002; ). Age-related changes in type 1 and type 2 cytokine production in humans. Biogerontology 3, 271–289.[CrossRef]
    [Google Scholar]
  10. Gibbons, R. J. ( 1992; ). How microorganisms cause diseases. In Infectious Diseases, pp. 7–106. Edited by S. L. Gorbach, J. G. Bartlett & N. R. Blacklow. Philadelphia: WB Saunders.
  11. Hacker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B. &, Wagner. H. ( 1998; ). CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17, 6230–6240.[CrossRef]
    [Google Scholar]
  12. Hartmann, G. & Krieg, A. M. ( 2000; ). Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164, 944–953.[CrossRef]
    [Google Scholar]
  13. Haruna, H., Inaba, M., Inaba, K. & 7 other authors ( 1995; ). Abnormalities of B cells and dendritic cells in SAMP1 mice. Eur J Immunol 25, 1319–1325.[CrossRef]
    [Google Scholar]
  14. Krieg, A. M., Matson, S. & Fisher, E. ( 1996; ). Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev 6, 133–139.[CrossRef]
    [Google Scholar]
  15. Mannon, R. B., Nataraj, C. & Pisetsky, D. S. ( 2000; ). Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides. Cell Immunol 201, 14–21.[CrossRef]
    [Google Scholar]
  16. Miller, R. A. ( 1996; ). The aging immune system: primer and prospectus. Science 273, 70–74.[CrossRef]
    [Google Scholar]
  17. Minutello, M., Senatore, F., Cecchinelli, G., Bianchi, M., Andreani, T., Podda, A. & Crovari, P. ( 1999; ). Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine 17, 99–104.[CrossRef]
    [Google Scholar]
  18. Monteiro, J. M., Harvey, C. & Trinchieri, G. ( 1998; ). Role of interleukin-12 in primary influenza virus infection. J Virol 72, 4825–4831.
    [Google Scholar]
  19. Moran, T. M., Isobe, H., Fernandez-Sesma, A. & Schulman, J. L. ( 1996; ). Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol 70, 5230–5235.
    [Google Scholar]
  20. Mori, I., Komatsu, T., Takeuchi, K., Nakakuki, K., Sudo, M. & Kimura, Y. ( 1995; ). Viremia induced by influenza virus. Microb Pathog 19, 237–244.[CrossRef]
    [Google Scholar]
  21. Oxenius, A., Martinic, M. M., Hengartner, H. & Klenerman, P. ( 1999; ). CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J Virol 73, 4120–4126.
    [Google Scholar]
  22. Pawelec, G., Adibzadeh, M., Pohla, H. & Schaudt, K. ( 1995; ). Immunosenescence: ageing of the immune system. Immunol Today 16, 420–422.[CrossRef]
    [Google Scholar]
  23. Ramshaw, I. A., Ramsay, A. J., Karupiah, G., Rolph, M. S., Mahalingam, S. & Ruby, J. C. ( 1997; ). Cytokines and immunity to viral infections. Immunol Rev 159, 119–135.[CrossRef]
    [Google Scholar]
  24. Rink, L., Cakman, I. & Kirchner, H. ( 1998; ). Altered cytokine production in the elderly. Mech Ageing Dev 102, 199–209.[CrossRef]
    [Google Scholar]
  25. Sparwasser, T., Koch, E. S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W. & Wagner, H. ( 1998; ). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28, 2045–2054.[CrossRef]
    [Google Scholar]
  26. Takeda, T., Hosokawa, H. & Higuchi K ( 1997a; ). Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp Gerontol 32, 105–109.[CrossRef]
    [Google Scholar]
  27. Takeda, T., Matsushita, T., Kurozumi, M., Takemura, K., Higuchi, K. & Hosokawa, M. ( 1997b; ). Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol 32, 117–127.[CrossRef]
    [Google Scholar]
  28. Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto E., Yano, O. & Tokunaga, T. ( 1992; ). Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 148, 4072–4076.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19029-0
Loading
/content/journal/jgv/10.1099/vir.0.19029-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error